(Press-News.org) In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people’s genetic risk of developing the disease, long before any symptoms appear.
Funded by an MS Australia Incubator Grant announced today, the Australian-first study will use a powerful new research method known as ‘recall by genotype’ to explore genetic causes of MS.
Specifically, the study will explore links between MS and the Epstein-Barr virus – a common virus best known for causing glandular fever, but increasingly believed to be a trigger for MS.
MS is a chronic autoimmune disease that disrupts communication between the brain, spinal cord and body. Affecting more than 33,000 Australians, the exact cause of MS remains unknown, though genetics and environmental factors are thought to play a key role.
Lead researcher, UniSA’s Dr David Stacey, says the research aims to untangle how the Epstein-Barr virus might lead to MS in some people but not others.
“For many years we’ve known that the Epstein-Barr virus is a likely precursor for MS,” Dr Stacey says.
“But because the virus affects up to 90% of the population, it’s difficult to pin down why some people go on to develop MS while others don’t.
“We believe the way a person’s immune system responds to the Epstein-Barr virus may be a key factor, and genetics can help us uncover that.”
The study will calculate MS genetic risk scores for more than 1000 South Australian participants without an MS diagnosis, then compare biological traits in a subset of participants with either high or low genetic risk.
“By grouping people based on their genetic profile, we expect to find those with a high genetic risk for MS will also show biological differences – even if they don’t have the disease,” Dr Stacey says. “That could reveal how the Epstein-Barr virus and MS are connected and identify early warning signs or biomarkers for MS.”
To enable this study, the researchers will use an innovative research design called ‘recall by genotype’ – or RbG for short. RbG studies use naturally occurring genetic variants that are strongly associated with a disease to group people for research. Participants are then ‘recalled’ for further testing based on their DNA, allowing researchers to study differences in a more targeted and reliable way.
The researchers have been working to establish resources to enable RbG studies in Australia, which until now have not been possible. This study will therefore help to establish standard operating procedures for participant recall and tackle important ethical questions about sharing genetic risk with research participants.
“If we identify people who are at risk of developing MS, we need to consider how – and whether – to share that information, particularly as this information may not yet be clinically actionable,” Dr Stacey says.
“This study will explore those ethical, legal and social questions to guide how future studies approach personal genetic risk.”
Ultimately, the research team – which includes collaborators from the Perron Institute and the University of Adelaide – hopes the study will pave the way for larger investigations and help support the development of early diagnostic tools and future preventative strategies for MS.
The University of South Australia and the University of Adelaide are joining forces to become Australia’s new major university – Adelaide University. Building on the strengths, legacies and resources of two leading universities, Adelaide University will deliver globally relevant research at scale, innovative, industry-informed teaching and an outstanding student experience. Adelaide University will open its doors in January 2026. Find out more on the Adelaide University website.
…………………………………………………………………………………………………………………………
Contact for interview: Dr David Stacey E: David.Stacey@unisa.edu.au
Media contact: Annabel Mansfield M: +61 479 182 489 E: Annabel.Mansfield@unisa.edu.au
END
Groundbreaking research to identify early signs of multiple sclerosis
2025-07-29
ELSE PRESS RELEASES FROM THIS DATE:
Designing drones that can fly in air ducts
2025-07-29
Air ducts: a contemporary issue for safety inspection
Air ducts are everywhere in modern buildings and underground networks, but are challenging to access for inspection. Their narrow dimensions and inability to support human weight prevent essential interventions to maintain air quality, heating, and air conditioning.
Small quadrotor drones offer a potential solution for exploring these air ducts because they can navigate both horizontal and vertical sections. However, they create airflows that recirculate inside the duct and destabilize the drone, creating important turbulences in an environment that has little space for error.
Mapping the aerodynamic forces in a ...
With no need for sleep or food, AI-built ‘scientists’ get the job done quickly
2025-07-29
Imagine you’re a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you need the expertise of a virologist and an immunologist, plus a bioinformatics specialist to help analyze and generate insights from your data. But you lack the resources or connections to build a big multidisciplinary team.
Researchers at Chan Zuckerberg Biohub San Francisco and Stanford University now offer a novel solution to this dilemma: an AI-driven Virtual Lab through which a team of AI agents, each equipped with varied scientific expertise, can tackle sophisticated and open-ended scientific problems by formulating, refining, ...
Blood tests show potential for colorectal cancer detection, but follow-up still falls short
2025-07-29
FINDINGS
A study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while blood-based tests offer a more convenient option for colorectal cancer screening, only 49% of patients completed a follow-up colonoscopy within six months, and just 56% did so at any point during the two-year study period. Follow-up colonoscopy is a critical next step to confirm the presence of colorectal cancer or pre-cancer after an abnormal screening result. These follow-up rates are comparable to those observed with stool-based screening tests, but remain far below optimal levels needed for timely cancer detection and treatment.
The team also found that individuals ...
A twangy timbre cuts through the noise
2025-07-29
WASHINGTON, July 29, 2025 — Twangy voices are a hallmark of country music and many regional accents. However, this speech type, often described as “brassy” and “bright,” can also be used to get a message across in a noisy environment.
In JASA Express Letters, published on behalf of the Acoustical Society of America by AIP Publishing, researchers from Indiana University found that it was easier to understand twangy female voices compared to neutral voices when surrounded by noise.
Found in accents in American cities such as Chicago, Boston, New York, ...
How does the immune system prepare for breastfeeding?
2025-07-29
LA JOLLA (July 29, 2025)—Of the 3.6 million babies born in the United States each year, around 80 percent begin breastfeeding in their first month of life. Breastfeeding has known benefits for both mother and child, reducing maternal risk of breast and ovarian cancers, type 2 diabetes, and high blood pressure, while simultaneously supporting the baby’s nutrition and immune system. But because pregnancy and lactation have been historically understudied, we still don’t understand the science behind many of these benefits.
Salk Institute immunologists are changing that—starting with a map of ...
Trends in medical and nonmedical use of prescription stimulants among US adolescents
2025-07-29
About The Study: Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and 2023, while nonmedical use decreased. Lifetime nonmedical use was more prevalent than medical use in early cohorts but shifted to being less prevalent in recent cohorts. These findings are consistent with declines in peer-to-peer diversion among adolescents following COVID-related school closures and findings from adult studies.
Corresponding ...
Trapping gut bacteria’s hidden fuel improves blood sugar and liver health, study shows
2025-07-29
A team of Canadian scientists has discovered a surprising new way to improve blood sugar levels and reduce liver damage: by trapping a little-known fuel made by gut bacteria before they wreak havoc on the body.
The findings, published in Cell Metabolism on July 29, 2025, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease.
Researchers at McMaster University, Université Laval and the University of Ottawa showed that a molecule produced by microbes in ...
Uncovering how a molecule responsible for immune “brakes” directs skin defenses
2025-07-29
Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early during infection, PD-1 acts like a steering wheel, guiding T cells to become protective resident memory T cells (TRM) that stay in place. These cells remember invading germs or cancer and quickly mount a response if that enemy reappears.
The preclinical findings, published July 29 ...
miRNA dysregulation of AGE/RAGE pathway in metabolic syndrome: a novel analysis strategy utilizing miRNA-profiling data
2025-07-29
Metabolic Syndrome (MetS), characterized by abdominal obesity, hypertension, dyslipidemia, and insulin resistance, represents a global health crisis with escalating prevalence. Its comorbidities—including type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), atherosclerosis, and polycystic ovary syndrome (PCOS)—share underlying molecular pathways. Among these, the receptor for advanced glycation end products (RAGE) and its ligands (AGEs, HMGB1, S100 proteins) form the AGE/RAGE axis, a key driver of inflammation, oxidative stress, and tissue damage in MetS. While targeting this axis is a promising therapeutic strategy, ...
AI catches one-third of interval breast cancers missed at screening
2025-07-29
OAK BROOK, Ill. – An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).
Interval breast cancers—symptomatic cancers diagnosed within a period between regular screening mammography exams—tend to have poorer outcomes due to their more aggressive biology and rapid growth. DBT, or 3D mammography, can improve visualization of breast lesions and reveal cancers that may be obscured by dense tissue. Because DBT is ...